Printer Friendly

PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES INITIAL PUBLIC OFFERING OF 2.5 MILLION SHARES OF COMMON STOCK

PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES INITIAL PUBLIC OFFERING
 OF 2.5 MILLION SHARES OF COMMON STOCK
 CAMBRIDGE, Mass., April 1 /PRNewswire/ -- PerSeptive Biosystems, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission for the proposed sale of 2.5 million shares of its common stock.
 All of the shares of common stock are being sold by the company. The offering will be managed by Alex. Brown & Sons Incorporated and Cowen & Company.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparation products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals.
 Prospectuses may be obtained from Alex. Brown & Sons Incorporated, 135 East Baltimore St., Baltimore, Md., 21202, Attn: David DePietro or Cowen & Company, Financial Square, 27th Floor, New York, N.Y. 10005.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. Information contained therein is subject to completion or amendment. These securities may not be sold, nor may offers to buy be accepted prior to the time that the registration statement becomes effective.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 -0- 4/1/92
 /CONTACT: James E. Coutre, president and CEO, PerSeptive Biosystems, 617-621-1787/ CO: PerSeptive Biosystems, Inc. ST: Massachusetts IN: MTC SU: OFR


EG -- NE006 -- 3790 04/01/92 09:56 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 1, 1992
Words:285
Previous Article:CONSUMERS POWER PROVIDES TREES TO BE PLANTED BY GIRL SCOUTS
Next Article:FEDERAL-MOGUL APPOINTS DIRECTOR OF CORPORATE FINANCE
Topics:


Related Articles
PERSEPTIVE BIOSYSTEMS ANNOUNCES FISCAL YEAR 1992 RESULTS
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES SECOND QUARTER RESULTS
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS; $0.05 EARNINGS PER SHARE BEFORE PTC-I BUYOUT
PERSEPTIVE BIOSYSTEMS AGREES TO ACQUIRE PERSEPTIVE TECHNOLOGIES II CORPORATION
PERSEPTIVE BIOSYSTEMS COMPLETES EXCHANGE OFFER FOR UNITS OF PERSEPTIVE TECHNOLOGIES II CORPORATION
PERSEPTIVE BIOSYSTEMS, INC. COMPLETES TRANSACTION WITH CHEMGENICS PHARMACEUTICALS
Energy BioSystems Completes $11 Million Financing
Perseptive Biosystems Realizes $12.9 Million From Selling Portion of Stock in Millennium Pharmaceuticals
LJL BioSystems, Inc. Announces Initial Public Offering
LJL BioSystems, Inc. Amends Initial Public Offering Registration Statement

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters